Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 124063, 15 pages
http://dx.doi.org/10.1155/2014/124063
Research Article

Cardioprotective Effects of Osteopontin-1 during Development of Murine Ischemic Cardiomyopathy

1Department of Cardiac Surgery, University Clinical Centre Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
2Department of Pediatric Cardiology, University Clinical Centre Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
3Department of Medicine I, University Clinical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany
4Department of Radiology, University Clinical Centre Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
5Department of Medicine II and Cardiology, University Clinical Centre Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
6Isar Heart Center, Isar Kliniken, Sonnenstraße 24-26, 80331 Munich, Germany
7Department of Anesthesiology and Intensive Care, University Clinical Centre Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany

Received 27 January 2014; Revised 21 April 2014; Accepted 23 April 2014; Published 29 May 2014

Academic Editor: Dario Coletti

Copyright © 2014 Georg D. Duerr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald, “Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop,” Circulation, vol. 97, no. 18, pp. 1848–1867, 1998. View at Google Scholar · View at Scopus
  2. N. G. Frangogiannis, S. Shimoni, S. Chang et al., “Active interstitial remodeling: an important process in the hibernating human myocardium,” Journal of the American College of Cardiology, vol. 39, no. 9, pp. 1468–1474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. G. Frangogiannis, S. Shimoni, S. M. Chang et al., “Evidence for an active inflammatory process in the hibernating human myocardium,” American Journal of Pathology, vol. 160, no. 4, pp. 1425–1433, 2002. View at Google Scholar · View at Scopus
  4. O. Dewald, N. G. Frangogiannis, M. Zoerlein et al., “Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2700–2705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. G. Frangogiannis, O. Dewald, Y. Xia et al., “Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy,” Circulation, vol. 115, no. 5, pp. 584–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. T. Denhardt, M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman, “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival,” Journal of Clinical Investigation, vol. 107, no. 9, pp. 1055–1061, 2001. View at Google Scholar · View at Scopus
  7. J. S. Berman, D. Serlin, X. Li et al., “Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 286, no. 6, pp. L1311–L1318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Lenga, A. Koh, A. S. Perera, C. A. McCulloch, J. Sodek, and R. Zohar, “Osteopontin expression is required for myofibroblast differentiation,” Circulation Research, vol. 102, no. 3, pp. 319–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Matsui, N. Jia, H. Okamoto et al., “Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy,” Hypertension, vol. 43, no. 6, pp. 1195–1201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. N. A. Trueblood, Z. Xie, C. Communal et al., “Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin,” Circulation Research, vol. 88, no. 10, pp. 1080–1087, 2001. View at Google Scholar · View at Scopus
  11. M.-A. Renault, F. Robbesyn, P. Réant et al., “Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy,” Circulation: Heart Failure, vol. 3, no. 3, pp. 431–439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Psarras, M. Mavroidis, D. Sanoudou et al., “Regulation of adverse remodelling by osteopontin in a genetic heart failure model,” European Heart Journal, vol. 33, no. 15, pp. 1954–1963, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Rittling, H. N. Matsumoto, M. D. Mckee et al., “Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro,” Journal of Bone and Mineral Research, vol. 13, no. 7, pp. 1101–1111, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Schrickel, K. Brixius, C. Herr et al., “Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice,” Cardiovascular Research, vol. 76, no. 2, pp. 257–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Huebener, T. Abou-Khamis, P. Zymek et al., “CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response,” Journal of Immunology, vol. 180, no. 4, pp. 2625–2633, 2008. View at Google Scholar · View at Scopus
  16. V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh, “Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 292, no. 1, pp. H673–H683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Graf, Y. S. Do, N. Ashizawa et al., “Myocardial osteopontin expression is associated with left ventricular hypertrophy,” Circulation, vol. 96, no. 9, pp. 3063–3071, 1997. View at Google Scholar · View at Scopus
  18. R. B. Driesen, F. K. Verheyen, W. Debie et al., “Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies,” Journal of Cellular and Molecular Medicine, vol. 13, no. 5, pp. 896–908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Omura, M. Yoshiyama, K. Takeuchi et al., “Differences in time course of myocardial mRNA expression in non-infarcted myocardium after myocardial infarction,” Basic Research in Cardiology, vol. 95, no. 4, pp. 316–323, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. D.-Y. Lu, W.-L. Yeh, S.-M. Huang, C.-H. Tang, H.-Y. Lin, and S.-J. Chou, “Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells,” Neuro-Oncology, vol. 14, no. 11, pp. 1367–1378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. U. Spahl, D. Berendji-Grün, C. V. Suschek, V. Kolb-Bachofen, and K.-D. Kröncke, “Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 13952–13957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Ophascharoensuk, C. M. Giachelli, K. Gordon et al., “Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis,” Kidney International, vol. 56, no. 2, pp. 571–580, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Sun, A. Feng, S. Chen et al., “Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1,” Cellular and Molecular Immunology, vol. 10, no. 2, pp. 176–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zheng, M. Toborek, and B. Hennig, “Epigallocatechin gallate-mediated protection against tumor necrosis factor-α-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent,” Metabolism: Clinical and Experimental, vol. 59, no. 10, pp. 1528–1535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Flück, S. I. Mund, J. C. Schittny, S. Klossner, A.-C. Durieux, and M.-N. Giraud, “Mechano-regulated tenascin-C orchestrates muscle repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13662–13667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Dewald, G. D. Duerr, N. Elhafi et al., “Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 961298, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Krishnamurthy, J. T. Peterson, V. Subramanian, M. Singh, and K. Singh, “Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction,” Molecular and Cellular Biochemistry, vol. 322, no. 1-2, pp. 53–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. E. Murry, C. M. Giachelli, S. M. Schwartz, and R. Vracko, “Macrophages express osteopontin during repair of myocardial necrosis,” American Journal of Pathology, vol. 145, no. 6, pp. 1450–1462, 1994. View at Google Scholar · View at Scopus
  29. P. Stawowy, F. Blaschke, P. Pfautsch et al., “Increased myocardial expression of osteopontin in patients with advanced heart failure,” European Journal of Heart Failure, vol. 4, no. 2, pp. 139–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. T. S. Kato, A. Chokshi, P. Singh et al., “Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure,” Journal of Heart and Lung Transplantation, vol. 31, no. 1, pp. 37–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Behnes, M. Brueckmann, S. Lang et al., “Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure,” European Journal of Heart Failure, vol. 15, no. 12, pp. 1390–1400, 2013. View at Publisher · View at Google Scholar